Patients In China Denied Innovative New Medicines, Says E.U. Pharmaceutical Group
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - A group of major European drug developers said Chinese patients are being denied innovative new medicines, according to press reports covering the most recent meeting of the pharmaceutical working group of the European Union Chamber of Commerce in China